Safety at events

Common Questions and Answers about Safety at events

safety

Avatar m tn Arrowhead intends to report additional data including pharmacokinetics and relative occurrence rates for adverse events in placebo and ARC-520 treatment groups at an appropriate venue when those data become available. The company plans to use the blinded analysis available now to move forward with a filing seeking approval to proceed with a Phase 2a trial in Hong Kong.
Avatar n tn As noted earlier, I washed thoroughly immediately after these two events. I appreciate your understanding, and hope you can ease my concerns, so I can clear my head for the future. Thank you, Doctor.
Avatar m tn 3 mg-4 mg) of GS-9620 demonstrated ISG15 and CCL8 mRNA induction without systemic IFNα related adverse events. We assessed the safety, tolerability and pharmacodynamics (PD) of GS-9620 in patients with chronic hepatitis B (CHB). Methods: A dose escalation (0.3 mg, 1 mg, 2 mg, 4 mg) placebo controlled study of a single dose or 2 doses one week apart, one in treatment naïve CHB patients and one in virologically suppressed CHB patients, is ongoing.
Avatar m tn Both events occurred when I was to come out of the lab after completion of work. Hence the glove was already taken off. My senior colleagues, including my employer, are never worried. Actually, they touched that kind of (potentially contaminated) environment without wearing gloves more often than not. I cannot take it easy just like they do, so I went here for the right answer.
572651 tn?1530999357 If you saw my email inbox you might be surprised at some of the mail I receive. I have signed up on distribution lists for many medical sites, including Nursing Times from the UK. I received an announcement today about an upcoming convention in LONDON, that may be of interest to some of you. This convention/conference is September 29-30 and the registration is FREE. I wish I could go, but its a bit far to commute. Some of you who live in the UK may be interested, though.
Avatar m tn In a Phase IIa combination trial in HCV patients, we reported data that showed that setrobuvir added to pegylated interferon and ribavirin accelerated the rate of viral clearance, with comparable response at setrobuvir doses of 200 mg bid and 400 mg bid. A single patient out of more than 60 exhibited viral breakthrough while receiving setrobuvir plus standard of care, corresponding to a low breakthrough rate of < 2%.
Avatar m tn 1%) had spontaneous abortion at the first trimester. Maternal and fetal adverse events are shown on Table 1. Most adverse events were mild in severity and considered unrelated to TDF. A higher percentage of mothers achieved HBV DNA 9. Among the 19 infants that have since reached the age of 7 months, 18 were tested and all were HBsAg(-). Conclusions: TDF treatment for the entire pregnancy period is safe and well-tolerated in pregnant women with active CHB.
Avatar m tn The safety and tolerability profile of telaprevir in the ADVANCE trial was consistent with the profile reported in Phase 2 studies, with an improvement in treatment discontinuation rates due to adverse events. Adverse events leading to discontinuation of all study drugs occurred in 6.9%, 7.7% and 3.6% of patients in the 12-week telaprevir-based arm, the 8-week telaprevir-based arm and the control arm, respectively.
Avatar m tn So a hepatologist at the transplant center has suggested triple therapy with Telaprevir for recurrence of Hep C and is going to help her with this treatment? Yes? While there is very little data available (only form very small studies- 10 or less patients) about the improvement of SVR rate over peg-interferon and Ribavirin, it is assumed that SVR rates are higher than with the 2 drug treatment. The SVR rate using only peg-INF and RBV among post transplant patients is only 30%.
408795 tn?1324935675 I remember somebody was on a clinical trial using eltrombopag or a facsimilie and I think the trial was halted within the first couple of weeks. At least it was halted for the person in it, as I remember. I'm just passing this information onward in case it is of interest to anyone. I thought eltrombopag was still in clinical trial, obviously I'm just here living and learning same as many. ------------------------ Message 3 From: U.S.
Avatar m tn You wisely used a condom and that ensured your safety. Unless there was a condom failure in either of your events, no risk can be associated. See a GP for your ailments, they are unspecific to HIV. You don't need to test.
Avatar m tn The DMC reviewed any potential drug discontinuations, incidence and details of adverse events, and selected laboratory assessments. No safety events in the DMC review were considered significantly different from those expected from HCV patients taking pegylated interferon and ribavirin treatment.
Avatar f tn t it show if drugs need to be developed to give at the time of chemotherapy to offset the effects of some of these long term side effects? It feels like the "dark ages" to not have a clearer understanding of how many perople are suffering these long term side effects.
1016004 tn?1254372364 1. Commit yourself to a Safety Contract – sign a contract stating to your safety, whether it be concerning self-harm, suicide, overeating, sexual behavior, etc. 2. Grounding Method – use a strategy to detach yourself from emotional pain (drug impulses, self-harm urges, etc.) by focusing on your outward external world. 3. Safe Place – an emotional detailed description of a scene or setting that would feel safe and soothing to you. 4.
Avatar m tn 5%) progressed to the stage of compensated cirrhosis and a single patient developed HCC; in the 47 cirrhotics at presentation, HCC occurred in 14 (30%) and events of liver failure in 5 (11%). The 5 and 10- year survival free of events was, respectively, 90.1% and 77% for patients with chronic hepatitis, and 71% and 43.7% for cirrhotics. Conclusions: The rationale beyond continuous NUCs administration is to attain and maintain viral clearance.
1932244 tn?1323292210 I'm a little confused by your question but doctors usually recommend at least a 3 -6 month interval before getting pregnant after a miscarriage.